Zydus` Generic Finasteride & Tadalafil Receives Approval in the U.S.
CINCINNATI, July 31, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and...
Enforcement Report - Week of April 12, 2023
Enforcement Report - Week of April 5, 2023
Enforcement Report - Week of March 8, 2023
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has launched two new prescription offerings -- Topical Finasteride & Minoxidil Spray and Oral Spironolactone -- to provide women with more effective solutions to address hair loss, which 1 in 3 women -- roughly 30 million women in the US alone -- experience at some time in their lives.
Enforcement Report - Week of May 20, 2020
MasterPharm, LLC. Issues Voluntary Nationwide Recall of Finasteride Plus 1.25mg
Reuters asked a U.S. judge on Thursday to unseal documents filed in court regarding potential risks associated with Propecia, Merck & Co’s (MRK.N) popular baldness drug.
HOBOKEN, N.J., Nov. 15, 2018 /PRNewswire/ -- According to the American Urological Association (AUA)1, over half of men experience symptoms of Benign Prostatic Hypertrophy, or enlarged prostate, by age 60, and nearly 90 percent do so by the age of 80. Enlarged prostate is one of the most common men's health conditions and leads to a number of uncomfortable and painful symptoms, including straining while urinating and increased frequency of bathroom visits. New peer-reviewed and published research shows that daily supplementation with the natural antioxidant Pycnogenol® (pic-noj-en-all) French maritime pine bark extract can reduce symptoms related to enlarged prostate within 60 days.